ArticleThe Journal of clinical and aesthetic dermatology2021

Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions.

Terry M Jones et al.PubMed ↗Full text ↗

No numbers read from the abstract.